{"event":"vaccines-mrna-tracker","title":"mRNA vaccines and RNA medicines tracker","state":"developing","updated":"2026-10-10T00:00:00.000Z","entries":[{"id":"1w9gn1g","at":"2026-09-15T00:00:00.000Z","title":"AAP v. Kennedy paused in district court pending appeal; ACIP has not met since March","status":"reported","cites":[{"id":"vaccines-mrna-aap-appeal","n":9,"url":"https://litigationtracker.law.georgetown.edu/litigation/american-academy-of-pediatrics-et-al-v-robert-f-kennedy-jr-et-al/","publisher":"Georgetown Law O'Neill Institute","short":"Georgetown Law O'Neill…"},{"id":"vaccines-mrna-acip-not-met","n":51,"url":"https://www.medicaldaily.com/aap-kennedy-vaccine-lawsuit-paused-october-6-appeal-478666","publisher":"Medical Daily","short":"Medical Daily"}]},{"id":"1ni8x7l","at":"2026-08-27T00:00:00.000Z","title":"FDA approves 2026-2027 COVID-19 vaccines, keeping narrower eligibility","status":"confirmed","cites":[{"id":"vaccines-mrna-covid-2026-27-approval","n":10,"url":"https://www.fda.gov/media/194509/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"},{"id":"vaccines-mrna-covid-2026-27-eligibility","n":11,"url":"https://www.fda.gov/vaccines-blood-biologics/comirnaty","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"1y9tnbb","at":"2026-08-19T00:00:00.000Z","title":"Personalised mRNA cancer therapy succeeds in phase 3 melanoma trial","status":"confirmed","cites":[{"id":"vaccines-mrna-interpath-met-endpoints","n":2,"url":"https://ascopost.com/news/august-2026/interpath-001-trial-of-mrna-based-individualized-neoantigen-therapy-meets-primary-and-key-secondary-endpoints-in-patients-with-high-risk-resected-melanoma/","publisher":"The ASCO Post","short":"The ASCO Post"},{"id":"vaccines-mrna-interpath-first","n":7,"url":"https://www.ajmc.com/view/moderna-merck-mrna-cancer-vaccine-succeeds-in-late-stage-trial","publisher":"AJMC","short":"AJMC"}]},{"id":"dn2cku","at":"2026-08-07T00:00:00.000Z","title":"mRESVIA label updated with pediatric study findings","status":"confirmed","cites":[{"id":"vaccines-mrna-mresvia-pediatric-label-2026","n":30,"url":"https://www.fda.gov/media/194169/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"1lpfec8","at":"2026-08-06T00:00:00.000Z","title":"FDA approves mFLUSIVA, the first mRNA flu vaccine","status":"confirmed","cites":[{"id":"vaccines-mrna-mflusiva-approval","n":1,"url":"https://www.biospace.com/press-releases/moderna-receives-u-s-fda-approval-for-influenza-vaccine-mflusiva","publisher":"Moderna (press release)","short":"Moderna"},{"id":"vaccines-mrna-mflusiva-efficacy","n":13,"url":"https://www.ajmc.com/view/fda-approves-moderna-s-mrna-flu-vaccine-after-phase-3-success","publisher":"AJMC","short":"AJMC"}]},{"id":"1bz21tp","at":"2026-07-31T00:00:00.000Z","title":"Moderna's norovirus vaccine misses early-success bar at phase 3 interim","status":"confirmed","cites":[{"id":"vaccines-mrna-moderna-norovirus-interim","n":21,"url":"https://www.sec.gov/Archives/edgar/data/0001682852/000168285226000147/exhibit9912026q2pressrelea.htm","publisher":"Moderna (SEC filing)","short":"Moderna"}]},{"id":"necdhi","at":"2026-07-30T00:00:00.000Z","title":"Alnylam's Amvuttra passes $1 billion in a quarter, though the company trims its guidance","status":"confirmed","cites":[{"id":"vaccines-mrna-alnylam-q2-2026-revenue","n":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000060/alny2026q2earningsrelease.htm","publisher":"Alnylam Pharmaceuticals (SEC filing)","short":"Alnylam Pharmaceuticals"},{"id":"vaccines-mrna-alnylam-guidance-cut","n":23,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000060/alny2026q2earningsrelease.htm","publisher":"Alnylam Pharmaceuticals (SEC filing)","short":"Alnylam Pharmaceuticals"}]},{"id":"yw64ie","at":"2026-05-29T00:00:00.000Z","title":"FDA picks the XFG variant for 2026-2027 COVID-19 vaccines","status":"confirmed","cites":[{"id":"vaccines-mrna-covid-2026-27-strain","n":16,"url":"https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"tmvxpu","at":"2026-05-19T00:00:00.000Z","title":"World Health Assembly extends negotiations on the Pandemic Agreement's PABS annex","status":"confirmed","cites":[{"id":"vaccines-mrna-pabs-extended","n":35,"url":"https://www.who.int/news/item/19-05-2026-seventy-ninth-world-health-assembly---daily-update--19-may-2026","publisher":"World Health Organization","short":"World Health Organization"}]},{"id":"uc1rur","at":"2026-04-14T00:00:00.000Z","title":"Maryland enacts law on state immunization recommendations, one of several states changing ACIP's role","status":"confirmed","cites":[{"id":"vaccines-mrna-md-vax-act","n":28,"url":"https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0637?ys=2026RS","publisher":"Maryland General Assembly","short":"Maryland General Assembly"},{"id":"vaccines-mrna-states-acip-laws-2026","n":29,"url":"https://www.astho.org/communications/blog/2026/2026-state-legislative-session-update/","publisher":"Association of State and Territorial Health Officials","short":"Association of State…"}]},{"id":"9l6mib","at":"2026-03-16T00:00:00.000Z","title":"Federal court stays ACIP appointments and votes since June 2025","status":"confirmed","cites":[{"id":"vaccines-mrna-aap-stay","n":6,"url":"https://www.cidrap.umn.edu/childhood-vaccines/state-us-vaccine-policy-special-edition-mar-17-2026","publisher":"CIDRAP (University of Minnesota)","short":"CIDRAP"},{"id":"vaccines-mrna-aap-court-findings","n":50,"url":"https://www.cidrap.umn.edu/childhood-vaccines/state-us-vaccine-policy-special-edition-mar-17-2026","publisher":"CIDRAP (University of Minnesota)","short":"CIDRAP"}]},{"id":"zy13br","at":"2026-02-20T00:00:00.000Z","title":"South Dakota House rejects bill against requirements for mRNA and other \"genetic-based\" vaccines","status":"confirmed","cites":[{"id":"vaccines-mrna-sd-hb1163","n":27,"url":"https://mylrc.sdlegislature.gov/api/Documents/Bill/298347.pdf?Year=2026","publisher":"South Dakota Legislature","short":"South Dakota Legislature"},{"id":"vaccines-mrna-sd-2026-covid-bills","n":49,"url":"https://www.yankton.net/community/article_acb9a2c9-9ff3-45d6-a819-11b33f5ea177.html","publisher":"South Dakota Searchlight","short":"South Dakota Searchlight"}]},{"id":"1dv5hqv","at":"2026-02-18T00:00:00.000Z","title":"FDA accepts Moderna's flu vaccine filing after an initial refusal to file","status":"confirmed","cites":[{"id":"vaccines-mrna-mflusiva-rtf","n":22,"url":"https://www.pharmacytimes.com/view/after-refusal-to-file-fda-reconsiders-moderna-s-mrna-flu-vaccine-with-higher-bar-for-seniors","publisher":"Pharmacy Times","short":"Pharmacy Times"}]},{"id":"yis8bx","at":"2025-12-18T00:00:00.000Z","title":"CEPI funds phase 3 of Moderna's H5 pandemic flu vaccine after US funding ended","status":"confirmed","cites":[{"id":"vaccines-mrna-cepi-moderna-h5","n":19,"url":"https://pharmaphorum.com/news/cepi-steps-fund-modernas-pandemic-flu-jab","publisher":"pharmaphorum","short":"pharmaphorum"},{"id":"vaccines-mrna-hhs-h5-cancel","n":39,"url":"https://pharmaphorum.com/news/cepi-steps-fund-modernas-pandemic-flu-jab","publisher":"pharmaphorum","short":"pharmaphorum"}]},{"id":"xyvyvw","at":"2025-12-03T00:00:00.000Z","title":"BioNTech's exchange offer for CureVac meets closing conditions","status":"confirmed","cites":[{"id":"vaccines-mrna-curevac-tender","n":48,"url":"https://www.sec.gov/Archives/edgar/data/1809122/000119312525306796/d63919d425.htm","publisher":"BioNTech / CureVac (SEC filing)","short":"BioNTech / CureVac"}]},{"id":"1socwn8","at":"2025-09-19T00:00:00.000Z","title":"Reconstituted ACIP moves COVID-19 vaccination to individual decision-making","status":"confirmed","cites":[{"id":"vaccines-mrna-acip-sept-2025","n":47,"url":"https://leadingage.org/acip-covid-vaccine-recommendations-shared-clinical-decision-making-no-prescriptions/","publisher":"LeadingAge","short":"LeadingAge"}]},{"id":"1cftqzz","at":"2025-08-25T00:00:00.000Z","title":"FDA limits Comirnaty label to 65+ and high-risk people, requires a placebo-controlled trial","status":"confirmed","cites":[{"id":"vaccines-mrna-fda-covid-label-2025","n":4,"url":"https://www.fda.gov/media/188486/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"},{"id":"vaccines-mrna-fda-rct-requirement","n":46,"url":"https://www.fda.gov/media/188486/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"lcz7dr","at":"2025-08-05T00:00:00.000Z","title":"HHS ends 22 BARDA mRNA vaccine investments worth about $500 million","status":"confirmed","cites":[{"id":"vaccines-mrna-barda-cancel","n":5,"url":"https://cancerletter.com/cancer-policy/20250808_5c/","publisher":"The Cancer Letter","short":"The Cancer Letter"},{"id":"vaccines-mrna-barda-rationale","n":24,"url":"https://cancerletter.com/cancer-policy/20250808_5c/","publisher":"The Cancer Letter","short":"The Cancer Letter"}]},{"id":"wh0slo","at":"2025-06-12T00:00:00.000Z","title":"FDA extends mRESVIA to higher-risk adults aged 18-59","status":"confirmed","cites":[{"id":"vaccines-mrna-mresvia-18-59","n":45,"url":"https://www.fda.gov/media/187046/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"1wx675k","at":"2025-05-30T00:00:00.000Z","title":"FDA approves Moderna's next-generation COVID-19 vaccine mNEXSPIKE","status":"confirmed","cites":[{"id":"vaccines-mrna-mnexspike-approval-2025","n":44,"url":"https://www.fda.gov/media/186740/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"},{"id":"vaccines-mrna-mnexspike-design","n":17,"url":"https://www.fda.gov/vaccines-blood-biologics/mnexspike","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"1piblqa","at":"2025-05-20T00:00:00.000Z","title":"Montana bill to ban mRNA vaccines for humans dies","status":"confirmed","cites":[{"id":"vaccines-mrna-montana-hb371","n":26,"url":"https://kffhealthnews.org/news/article/mrna-vaccines-trump-boast-under-gop-attacks-legislation/","publisher":"KFF Health News","short":"KFF Health News"},{"id":"vaccines-mrna-state-bills-2025","n":18,"url":"https://kffhealthnews.org/news/article/mrna-vaccines-trump-boast-under-gop-attacks-legislation/","publisher":"KFF Health News","short":"KFF Health News"}]},{"id":"1f3oow7","at":"2025-03-20T00:00:00.000Z","title":"FDA approves Amvuttra for ATTR cardiomyopathy","status":"confirmed","cites":[{"id":"vaccines-mrna-amvuttra-attr-cm","n":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867025000038/pressreleaseforcmapproval.htm","publisher":"Alnylam Pharmaceuticals (SEC filing)","short":"Alnylam Pharmaceuticals"}]},{"id":"2pwa1m","at":"2025-02-14T00:00:00.000Z","title":"EU authorizes Kostaive, the first self-amplifying mRNA COVID-19 vaccine in the EU","status":"confirmed","cites":[{"id":"vaccines-mrna-kostaive-ec","n":38,"url":"https://newsroom.csl.com/2025-02-14-European-Commission-Approves-CSL-and-Arcturus-Therapeutics-KOSTAIVE-R-,-the-First-Self-amplifying-mRNA-COVID-19-Vaccine","publisher":"CSL (press release)","short":"CSL"}]},{"id":"10fz3h1","at":"2024-05-31T00:00:00.000Z","title":"FDA approves Moderna's RSV vaccine mRESVIA for adults 60 and older","status":"confirmed","cites":[{"id":"vaccines-mrna-mresvia-approval-2024","n":43,"url":"https://www.fda.gov/media/179015/download","publisher":"US Food and Drug Administration","short":"US Food and Drug…"}]},{"id":"5naqvs","at":"2023-10-02T00:00:00.000Z","title":"Nobel Prize recognises nucleoside-modified mRNA","status":"confirmed","cites":[{"id":"vaccines-mrna-nobel-2023","n":42,"url":"https://news.ki.se/the-nobel-prize-in-physiology-or-medicine-2023-to-katalin-kariko-and-drew-weissman","publisher":"Karolinska Institutet","short":"Karolinska Institutet"}]},{"id":"1swokgu","at":"2018-08-10T00:00:00.000Z","title":"FDA approves Onpattro, the first RNAi therapeutic","status":"confirmed","cites":[{"id":"vaccines-mrna-onpattro-first-rnai","n":41,"url":"https://investors.alnylam.com/press-release?id=22946","publisher":"Alnylam Pharmaceuticals (press release)","short":"Alnylam Pharmaceuticals"}]}]}